Kimon Kotronis
Director, Technology Consulting
A medical doctor and avid technologist, Kimon has over 15 years of experience providing technology advisory and consultancy services to the Healthcare and Life Sciences industry, designing, developing and delivering technology solutions and systems to most of the top 20 Pharmaceutical companies. With a career spanning all aspects of the technology and data value chain in global life sciences companies and public and private healthcare organizations, he uniquely combines technology and digital transformation leadership through the creation of high performing Agile teams with domain knowledge and data management and governance skills.
As a Director in the Technology Consulting team, Kimon leads architecture and development of custom solutions that leverage Clarivate data, integrating it with third party sources and customers’ own datasets to derive unique insights using intelligent visualizations, natural language processing, data analytics and AI technologies.
Kimon has written about and presented to international conferences on the challenges of data harmonization and digital product development for the generation of actionable insights in highly regulated environments. He has a MD from the Aristotle University of Thessaloniki, Greece, a MSc in Health Informatics from City University, London and a MBA from Bayes Business School, London.
Latest news
Clarivate Webinar “Intelligence Amplified in the Age of AI” Highlights How Trusted, Proprietary Data Powers Next Generation Innovation
London, UK – February 3, 2026, Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today announced the launch of a video webinar, Intelligence Amplified in the Age…
Clarivate Announces Full Redemption of Remaining $100 Million Senior Secured Notes Due 2026 and Provides Update on Capital Allocation Activities
London, UK – February 2, 2026, Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today announced that its subsidiary, Camelot Finance S.A., has redeemed the remaining $100…
Clarivate to Report Fourth Quarter and Full Year 2025 Results on February 24, 2026
London, U.K., January 28, 2026 – (PR Newswire) – Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today announced it will report its financial results for the fourth…